ArticleEuropean journal of immunology2022

SARS-CoV-2-specific T cells are generated in less than half of allogeneic HSCT recipients failing to seroconvert after COVID-19 vaccination.

Andrea Jarisch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.